Determination of the Commercialization Pathway for Advanced Chitosan-Based Hemostatic Biomaterials for Medical Applications

Beneficiary: Cracow University of Technology

Head Researcher: Radwan-Pragłowska Julia

Call: 1/2024

Amount of Funding: 313 904,00